The effect of tryptophan depletion on alcohol self-administration in non-treatment-seeking alcoholic individuals

Alcoholism: Clinical and Experimental Research

Volumn 26, Issue 7, 2002, Pages 969-975

  Petrakis, Ismene L ^a,b   Buonopane, Alessandra ^a   O'Malley, Stephanie ^a   Cermik, Omer ^a   Trevisan, Louis ^a   Boutros, Nashaat N ^a   Limoncelli, Diana ^a   Krystal, John H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Alcohol; Alcoholism; Self Administration; Serotonin; Tryptophan Depletion

Indexed keywords

ALCOHOL; PLACEBO; SEROTONIN; TRYPTOPHAN;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; AMINO ACID DEFICIENCY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; MALE; NEUROBIOLOGY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; ADDICTION; ADOLESCENT; ALCOHOLIC BEVERAGE; ANALYSIS OF VARIANCE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; METABOLISM; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ALCOHOL DRINKING; ALCOHOLIC BEVERAGES; ALCOHOLISM; ANALYSIS OF VARIANCE; BEHAVIOR, ADDICTIVE; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; HUMANS; MALE; SELF ADMINISTRATION; TRYPTOPHAN;

EID: 0035995975     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2002.tb02629.x     Document Type: Article

References (50)

1. Alcohol and central serotonin metabolism in man
2. Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics
3. Age of alcoholism onset. II. Relationship to susceptibility to serotonin precursor availability
4. Tryptophan depletion during continuous CSF sampling in healthy human subjects
5. Pharmacologic intervention for abusers of alcohol and cocaine: A pilot study of disulfiram versus naltrexone
6. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men
7. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial
8. Ethanol intake and 3H-serotonin uptake. II: A study in alcoholic patients using platelets 3H-paroxetine binding
9. Effects of naltrexone on alcohol self-administration in heavy drinkers
10. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan
11. Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects
12. Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects
13. Blockade of the discriminative stimulus effects of ethanol with 5-HT3 receptor antagonists
14. Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose
15. Cellular and behavioral neurobiology of alcohol: Receptor-mediated neuronal processes
16. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates
17. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients - A randomized controlled trial
18. Ritanserin in the treatment of alcohol dependence - A multi-center clinical trial
19. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism
20. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics
21. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics
22. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms
23. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects
24. Acute tyrosine depletion and alcohol ingestion in healthy women
25. Reactivity to alcohol-related stimuli in the laboratory and in the field: Predictors of craving in treated alcoholics
26. A placebo-controlled trial of buspirone in anxious inpatient alcoholics
27. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index
28. The role of selective serotonin reuptake inhibitors in reducing alcohol consumption
29. Suicidality and 5-hydroxyindoleacetic acid concentration assoziated with a tryptophan hydroxylase polymorphism
30. TPH replication study: Not
31. Naltrexone decreases craving and alcohol self administration in alcohol dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis
32. Neuroscience: Implications of treatment
33. Effect of tryptophan depletion on alcohol cue-induced craving in abstinent alcoholic patients
34. CSF monoamine metabolite and beta-endorphin levels in recently detoxified alcoholics and healthy controls: Prediction of alcohol cue-induced craving
35. Give them prizes, and they will come: Contingency management for treatment of alcohol dependence
36. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes
37. Role of serotonin and serotonin-selective pharmacotherapy in alcohol dependence
38. Influence of tryptophan availability on selection of alcohol and water by men
39. Platelet serotonin uptake in men with family histories of alcoholism
40. A comparison of progressive ratio schedules versus behavioral economic measures: Effect of an alternative reinforcer on the reinforcing efficacy of phencyclidine
41. Reduced central serotonin turnover in a subgroup of alcoholics?
42. Dopamine D1, D2 and D3 receptor genes in alcohol dependence
43. Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations
44. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description
45. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)
46. Challenges in the manipulation assessment and interpretation of craving relevant variables
47. Development and validation of a questionnaire on smoking urges
48. Platelet MAO activity as a biological marker in subgroups of alcoholism
49. The influence of altered tryptophan availability on ethanol intoxication in normal men